Cti Biopharma Corp

NORTHERN TRUST CORP

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

847,737

Value ($000)

3,560

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	3,560	0.0%	847,737	3/31/2023
2022 Q4	2/13/2023	5,189	0.0%	863,406	12/31/2022
2022 Q3	11/14/2022	4,682	0.0%	804,519	9/30/2022
2022 Q2	8/12/2022	4,510	0.0%	755,419	6/30/2022
2022 Q1	5/13/2022	627	0.0%	134,185	3/31/2022
2021 Q4	2/8/2022	337	0.0%	135,693	12/31/2021
2021 Q3	11/15/2021	373	0.0%	126,259	9/30/2021
2021 Q2	8/13/2021	316	0.0%	126,259	6/30/2021
2021 Q1	5/12/2021	294	0.0%	100,753	3/31/2021
2020 Q4	2/11/2021	316	0.0%	98,115	12/31/2020
2020 Q3	11/16/2020	224	0.0%	104,402	9/30/2020
2020 Q2	8/14/2020	113	0.0%	97,371	6/30/2020
2020 Q1	5/14/2020	104	0.0%	113,273	3/31/2020
2019 Q4	2/14/2020	141	0.0%	89,062	12/31/2019